Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 17,977-17,988 of 23,847
Drug study icon
TerminatedNCT04634669

Safety study of AXS-05 in Depression

This study was terminated in the United States. It is testing AXS-05 for Depression.

Multiple locations, including Little Rock
DepressionDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
Axsome Therapeutics, Inc.
Condition
Depression
Drug study icon
Enrolling By InvitationNCT06878976

Safety study of solriamfetol in Eating disorders

This study is enrolling by invitation in the United States. It is testing solriamfetol for Eating disorders.

Multiple locations, including Encino
Eating disordersDrugFrom 18 Years to 56 Years
Countries
United States
Sponsor
Axsome Therapeutics, Inc.
Condition
Eating disorders
Other study type icon
CompletedNCT01875822

Study of Curcumin C-3 Complex in Schizophrenia

This study is completed in the United States. It is testing Curcumin C-3 Complex for schizophrenia.

In San Juan
Schizophrenia, DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Woodbury, Michel, M.D.
Condition
Schizophrenia, Depression
Drug study icon
WithdrawnNCT01932541

Latuda for Bipolarity

This study was withdrawn in the United States. It is testing latuda for Bipolarity.

In Boston
BipolarityDrugFrom 6 Years to 17 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.